THE PREVALENCE OF DYSLIPIDEMIA IN THE POPULATION OF THE REPUBLIC OF MOLDOVA (PRELIMINARY DATA)
DOI:
https://doi.org/10.52692/1857-0011.2024.1-78.30Keywords:
dyslipidemia, LDL-cholesterol, cardiovascular risc, triglyceridesAbstract
Introduction. Dyslipidemias are among the most important modifiable risk factors associated with cardiovascular pathology. Materials and methods. The preliminary results of the observational, cross-sectional study conducted from February 2020 to January 2023 are presented. The prevalence of dyslipidemia and the lipid profile in a sample of 728 participants from rural and urban environments were analyzed. Results: In a group of participants with a mean age of 47.14 ± 12.65 years, it was observed that elevated LDL- cholesterol and decreased HDL-cholesterol levels were the most frequent abnormal lipid parameters in men, and in women isolated elevation of LDL-cholesterol was often recorded. Conclusions: The study emphasizes the importance of early screening in apparently healthy populations. Early diagnosis may identify high-risk population groups, where early intervention may lead to avoidance of later complications related to dyslipidemia.
References
Authors/Task Force Members; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Atherosclerosis, 2019; 290:140 – 205 .
Bamba V., Rader D.J. Obesity and atherogenic dyslipidemia. Gastroenterology, 2007; 132:2181– 2190. two: 10.1053/j.gastro.2007.03.056.
Steinhagen-Thiessen E., Bramlage P., Lösch C. et al. Dyslipidemia in primary care – prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol., 2008; 7 , 31 . https://doi.org/10.1186/1475-2840-7-31
Vaduganathan M., Mensah G., Turco J. et al. The Global Burden of Cardiovascular Diseases and Risk. J Am Coll Cardiol., 2022; 80 (25): 2361–2371. https://doi.org/10.1016/j.jacc.2022.11.005.
World Health Organisation. Global status report on noncommunicable diseases 2014 (World Health Organization, 2014).
Moscalu V., Rudi V., Marina A., Batrînac A. Availability of cardiovascular medical care services, mortality and burden of morbidity due to cardiovascular diseases in the Republic of Moldova in the context of european statistical data. Buletinul AȘM. Științe medicale, 2020; 65(1):67-93. https://ibn.idsi.md/sites/default/files/imag_file/67-93_compressed.pdf
Peng J., Zhao F., Yang X. et al. Association between dyslipidemia and risk of type 2 diabetes mellitus in middle-aged and older Chinese adults: a secondary analysis of a nationwide cohort. BMJ Open, 2021; 25:11(5):e042821. doi: 10.1136/bmjopen-2020-042821. PMID: 34035089; PMCID: PMC8154929.
Beazer J.D., Freeman D.J. Estradiol and HDL Function in Women - A Partnership for Life. J Clin Endocrinol Metab., 2022; 19(5):107:e2192-e2194.doi:10.1210/clinem/dgab811.PMID:34788853;PMCID: PC9016454.
Downloads
Published
License
Copyright (c) 2024 Bulletin of the Academy of Sciences of Moldova. Medical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
